AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00%

ECS ECS Botanics Holdings Ltd

Healthcare · Drug Manufacturers - Specialty & Generic · website
$0.01
52wk 0.00 – 0.01
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About ECS Botanics Holdings Ltd

ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally. It is involved in the agriculture business. ECS Botanics Holdings Ltd is based in Murrabit, Australia.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$9.61M
P/E (trailing)
P/E (forward)
EPS (trailing)
0.00
Dividend yield
Payout ratio
0.0%
Beta
EV / EBITDA
-18.88
Price / Book
0.18
ROE
Operating margin
2.8%
Net margin
0.0%
Total cash
$1.31M
Total debt
$6.61M
Current ratio
56.73
Debt / Equity
0.28
Free cash flow
Avg volume
1.19M
Latest annual results (FY ending 30 Jun 2024)
  • Revenue$20.03M
  • Gross profit$9.13M
  • Operating income$1.74M
  • Net income$1.99M
  • Diluted EPS0.00
  • Free cash flow-$3.88M
  • Net debt-$2.13M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $59.53B 14.0
RMD $43.89B 20.4
SIG $34.28B 59.4
FPH $20.25B 52.2
PME $17.21B 73.5
SHL $10.79B 19.7
RHC $10.13B 34.8
COH $7.90B 22.9